X4 Pharmaceuticals, Inc

XFOR · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
213
SEC Filings

Business Summary

Overview We are a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. Our goal is to build a profitable company by generating income from products we develop and commercialize, either alone or with partners. Our primary asset is mavorixafor, a small molecule delivered in a capsule for oral dosing as a selective antagonist of the chemokine receptor, CXCR4. We have one commercially approved product, XOLREMDI (mavorixafor), whic...

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionXFORdiscussed_in_filing Cybersecurity
topic_mentionXFORdiscussed_in_filing Trusted Computing
topic_mentionXFORdiscussed_in_filing Blockchain & Crypto
topic_mentionXFORdiscussed_in_filing Regulation
topic_mentionXFORdiscussed_in_filing Healthcare & Bio
topic_mentionXFORdiscussed_in_filing Cybersecurity
topic_mentionXFORdiscussed_in_filing Trusted Computing
topic_mentionXFORdiscussed_in_filing Blockchain & Crypto
topic_mentionXFORdiscussed_in_filing Regulation
topic_mentionXFORdiscussed_in_filing Healthcare & Bio
topic_mentionXFORdiscussed_in_filing Cybersecurity
topic_mentionXFORdiscussed_in_filing Trusted Computing
topic_mentionXFORdiscussed_in_filing Blockchain & Crypto
topic_mentionXFORdiscussed_in_filing Regulation
topic_mentionXFORdiscussed_in_filing Healthcare & Bio
topic_mentionXFORdiscussed_in_filing Cybersecurity
topic_mentionXFORdiscussed_in_filing Trusted Computing
topic_mentionXFORdiscussed_in_filing Blockchain & Crypto
topic_mentionXFORdiscussed_in_filing Regulation
topic_mentionXFORdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-172025-12-310001501697-26-000018EDGAR86K words
2025-03-262024-12-310001628280-25-014805EDGAR—
2024-03-212023-12-310001628280-24-012578EDGAR—
2023-03-212022-12-310001628280-23-008745EDGAR—
2022-03-172021-12-310001628280-22-006547EDGAR—
2021-03-192020-12-310001628280-21-005202EDGAR—
2020-03-122019-12-310001628280-20-003484EDGAR—
2019-03-112018-12-310001564590-19-007097EDGAR—
2018-03-092017-12-310001564590-18-005038EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001501697-25-000043EDGAR21K words
2025-08-082025-06-300001628280-25-039327EDGAR—
2025-05-012025-03-310001628280-25-021358EDGAR—
2024-11-132024-09-300001628280-24-047445EDGAR—
2024-08-082024-06-300001628280-24-036127EDGAR—
2024-05-072024-03-310001628280-24-021120EDGAR—
2023-11-092023-09-300001628280-23-038334EDGAR—
2023-08-102023-06-300001628280-23-028897EDGAR—
2023-05-042023-03-310001628280-23-015763EDGAR—
2022-11-032022-09-300001628280-22-028201EDGAR—
2022-08-042022-06-300001628280-22-021070EDGAR—
2022-05-122022-03-310001628280-22-014095EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-11-050001501697-25-000041EDGAR2K words
2025-10-270001501697-25-000032EDGAR—
2025-09-170001501697-25-000021EDGAR—
2025-08-250001501697-25-000008EDGAR—
2025-08-130001501697-25-000006EDGAR—
2025-08-120001628280-25-039770EDGAR—
2025-06-230001628280-25-032627EDGAR—
2025-06-110001628280-25-030743EDGAR—
2025-05-010001628280-25-021304EDGAR—
2025-04-240001628280-25-019507EDGAR—

213 total filings indexed. 182 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001501697
TickerXFOR
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 607d4073b07fa2476add5d77c9b74a6587e9eaa6ad366a32750d48d4c18acc50
parent: fef55c0578cded2e5da6347482ad4d29ba1892856f3c1bb8b58103236f00695e
content hash: 55158c870fd1277dd13bb82032fb8c8c2b7115d5aaba8b8fc7559da5310258ae
signed: 2026-04-13T04:48:17.930Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf